price
AB
NYSE · ABBV
AbbVie Inc.
Healthcare · Drug Manufacturers - General
$264.34
Down-$0.72 (-0.27%)
Updated Sep 28, 2026, 8:54 AM
SID Score
7.1/10
Composite research score
Smart Money
56/100
Neutral
- Market cap
- 410.09B
- P/E ratio
- 97.75
- Dividend yield
- 3.14%
- 52-week range
- $190.75 – $269.39
- Volume
- 2.54M
- Avg. volume
- 6.4M
Price performance
ABBV price history
1M range · 19 trading sessions · Daily adjusted prices
ABBV closed at $264.34 after 19 trading sessions, up 3.09% for the selected period.
- Last close
- $264.34
- Period change
- +3.09%
- Period low
- $248.78
- Period high
- $265.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $265.49 | $266.00 | $262.59 | $264.34 | 2.54M |
| Sep 24, 2026 | $265.37 | $267.41 | $263.09 | $265.12 | 3.46M |
| Sep 23, 2026 | $266.00 | $269.39 | $263.5885 | $265.08 | 3.47M |
| Sep 22, 2026 | $263.10 | $266.82 | $262.145 | $265.21 | 2.77M |
| Sep 21, 2026 | $263.07 | $266.5998 | $261.23 | $264.48 | 3.44M |
| Sep 18, 2026 | $263.29 | $266.34 | $262.44 | $263.96 | 8.18M |
| Sep 17, 2026 | $262.61 | $264.62 | $260.88 | $264.02 | 3.51M |
| Sep 16, 2026 | $261.99 | $264.00 | $260.975 | $262.51 | 3.12M |
| Sep 15, 2026 | $260.00 | $264.81 | $257.795 | $263.04 | 5.12M |
| Sep 14, 2026 | $261.67 | $264.6499 | $260.1001 | $261.77 | 4.51M |
| Sep 11, 2026 | $253.92 | $259.61 | $253.92 | $257.12 | 4.31M |
| Sep 10, 2026 | $251.23 | $255.31 | $249.735 | $255.00 | 4.4M |
| Sep 9, 2026 | $247.73 | $251.18 | $246.7701 | $250.91 | 3.87M |
| Sep 8, 2026 | $251.84 | $254.615 | $248.41 | $248.78 | 5.57M |
| Sep 4, 2026 | $257.96 | $258.91 | $255.58 | $256.46 | 4.73M |
| Sep 3, 2026 | $264.00 | $264.25 | $257.14 | $260.21 | 2.88M |
| Sep 2, 2026 | $262.70 | $262.97 | $257.70 | $261.72 | 4.23M |
| Sep 1, 2026 | $260.99 | $262.265 | $257.79 | $259.99 | 3.87M |
| Aug 31, 2026 | $254.17 | $258.24 | $252.33 | $256.42 | 4.32M |
Latest ABBV news
The latest Smart Investors Daily articles mentioning ABBV.
Stock researchResearch & News · News
Loading stock research…